These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20727278)

  • 1. [A randomized study of docetaxel plus cisplatin versus paclitaxel plus cisplatin in previously untreated advanced non-small cell lung cancer.].
    Zhang S; Wang J; Wang Q; Yang X; Hu F; Li X; Gu Y; Wang H
    Zhongguo Fei Ai Za Zhi; 2008 Feb; 11(1):110-4. PubMed ID: 20727278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A randomized clinical trial on taxol plus oxaliplatin versus taxol plus cisplatin as first-line treatment in advanced non-small cell lung cancer].
    Li M; Huang H; Tan J; Lin D
    Zhongguo Fei Ai Za Zhi; 2006 Oct; 9(5):452-4. PubMed ID: 21176470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A randomized study comparing topotecan plus cisplatin versus etoposide plus carboplatin for previously untreated small cell lung cancer].
    Zhang S; Wang J; Wang Q; Zhang H; Hu F; Yang X; Fan X; Wang H; Gu Y; Li X
    Zhongguo Fei Ai Za Zhi; 2007 Apr; 10(2):144-7. PubMed ID: 21114940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer].
    Li DX; Chen XB
    Ai Zheng; 2002 Apr; 21(4):412-5. PubMed ID: 12452023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase II trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer.
    Arrieta O; González-De la Rosa CH; Aréchaga-Ocampo E; Villanueva-Rodríguez G; Cerón-Lizárraga TL; Martínez-Barrera L; Vázquez-Manríquez ME; Ríos-Trejo MA; Alvarez-Avitia MA; Hernández-Pedro N; Rojas-Marín C; De la Garza J
    J Clin Oncol; 2010 Jul; 28(21):3463-71. PubMed ID: 20547984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel steady-state plasma concentration as a determinant of disease outcome and toxicity in lung cancer patients treated with paclitaxel and cisplatin.
    Rowinsky EK; Jiroutek M; Bonomi P; Johnson D; Baker SD
    Clin Cancer Res; 1999 Apr; 5(4):767-74. PubMed ID: 10213211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Randomized clinical study comparing gemcitabine and oxaliplatin versus gemcitabine and cisplatin for advanced non-small cell lung cancer in elderly patients].
    Sun Q; Hua J; Hang X; Mao Y; Wang Q
    Zhongguo Fei Ai Za Zhi; 2005 Oct; 8(5):451-3. PubMed ID: 21205532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
    Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gemcitabine plus cisplatin versus navelbine plus cisplatin in the treatment of advanced non-small cell lung cancer].
    Fan Y; Luo L
    Zhongguo Fei Ai Za Zhi; 2003 Dec; 6(6):499-501. PubMed ID: 21310141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the Clinical Effects of Paclitaxel and Paclitaxel plus Oxaliplatin as the Second-line Treatment of Advanced Non-small Cell Lung Cancer.].
    Chu T; Lin H; Shen J; Zhong R; Han B
    Zhongguo Fei Ai Za Zhi; 2009 Nov; 12(11):1178-83. PubMed ID: 20723367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial.
    Socinski MA; Bondarenko I; Karaseva NA; Makhson AM; Vynnychenko I; Okamoto I; Hon JK; Hirsh V; Bhar P; Zhang H; Iglesias JL; Renschler MF
    J Clin Oncol; 2012 Jun; 30(17):2055-62. PubMed ID: 22547591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A randomized clinical trial of gemcitabine plus cisplatin compared with gemcitabine plus vinorelbine in the treatment of non-small cell lung cancer].
    Zhang L; Li N; Xu F; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2005 Dec; 8(6):530-4. PubMed ID: 21208543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
    Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L
    Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients].
    Wang J; Sun Y; Liu Y; Yu Q; Zhang Y; Li K; Zhu Y; Zhou Q; Hou M; Guan Z; Li W; Zhuang W; Wang D; Liang H; Qin F; Lu H; Liu X; Sun H; Zhang Y; Wang J; Luo S; Yang R; Tu Y; Wang X; Song S; Zhou J; You L; Wang J; Yao C
    Zhongguo Fei Ai Za Zhi; 2005 Aug; 8(4):283-90. PubMed ID: 21108883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Randomized clinical trial of paclitaxel plus cisplatin versus gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer].
    Gou H; Chen X; Hou M; Yang Y
    Zhongguo Fei Ai Za Zhi; 2007 Apr; 10(2):141-3. PubMed ID: 21114939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination of docetaxel and cisplatin in the treatment of advanced non-small cell lung cancer].
    Liu H; Hou M; Zhu J; Li L; Qiu M; Yan X
    Zhongguo Fei Ai Za Zhi; 2002 Oct; 5(5):352-3. PubMed ID: 21329604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study on gemcitabine plus cisplatin and vinorelbine plus ifosfamide plus cisplatin combined chemotherapy in the treatment of advanced non-small cell lung cancer].
    Zhao Y; Chen Y; Ji H; Chu T; Han B; Liao M
    Zhongguo Fei Ai Za Zhi; 2004 Oct; 7(5):449-51. PubMed ID: 21244803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of navelbine plus ifosfamide and cisplatin versus ifosfamide plus cisplatin in the treatment of advanced non small cell lung cancer].
    Liao G; Wang H; Qu Y; Liu P; Xie G; Dai H
    Zhongguo Fei Ai Za Zhi; 2003 Apr; 6(2):138-40. PubMed ID: 21262166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination chemotherapy with docetaxel and cisplatin in weekly schedule in the treatment of 30 cases of advanced non-small cell lung cancer].
    Zhang Y; Yu L; Chen W
    Zhongguo Fei Ai Za Zhi; 2001 Jun; 4(3):197-9. PubMed ID: 21047477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of navelbine combined with cisplatin in the treatment of advanced non-small cell lung cancer].
    He Y
    Zhongguo Fei Ai Za Zhi; 2004 Dec; 7(6):517-9. PubMed ID: 21251412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.